The pharmaceutical polymer vials market is growing fast and is expected to bring in hundreds of millions in revenue from 2025 to 2034. The rising demand for advanced drugs and injectables, along with ongoing innovations in the pharmaceutical industry, is driving this growth.
Top Companies in the Pharmaceutical Polymer Vials Market
- SCHOTT Pharma
- West Pharmaceutical Services
- Gerresheimer AG
- SGD Pharma
- Stevanato Group
- SiO2 Materials Science
- Bormioli Pharma
- Berry Global
- Nipro Corporation
- Corning Incorporated
- Origin Pharma Packaging
- DWK Life Sciences
- Catalent Inc.
- Adelphi Healthcare Packaging
- Medtronic (Pharmaceutical Packaging Division)
- Thermo Fisher Scientific
- BD (Becton, Dickinson and Company)
- Amcor Plc
- AptarGroup, Inc.
- Ompi (a Stevanato Group company)
Latest Announcements by the Pharmaceutical Polymer Vials Market
- In January 2025, CEO of SCHOTT Pharma, Andreas Reisse, expressed, “With the advancement of polymer syringe process, we are raising the evolution standard in the pharmaceutical industry by offering a process which confirm packaging that maintain the stability of the drugs, enhance the operational efficacy, and decrease valuable drugs and waste generation during packaging.”
Recent Developments
- In January 2024, SCHOTT Pharma announced the launch of new vials for gene therapy and mRNA medication. It is developed with an aim to provide contamination free packaging of the products.
- In April 2025, Syntegon announced the launch of MLD Advanced to fulfil the rising need of pharmaceutical producer high output 100% IPC.
